Free Trial

Teladoc Health (TDOC) Competitors

Teladoc Health logo
$7.48 +0.14 (+1.84%)
As of 10:47 AM Eastern
This is a fair market value price provided by Massive. Learn more.

TDOC vs. AMZN, CRSP, ROKU, ZM, and AMWL

Should you buy Teladoc Health stock or one of its competitors? MarketBeat compares Teladoc Health with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Teladoc Health include Amazon.com (AMZN), CRISPR Therapeutics (CRSP), Roku (ROKU), Zoom Communications (ZM), and American Well (AMWL).

How does Teladoc Health compare to Amazon.com?

Amazon.com (NASDAQ:AMZN) and Teladoc Health (NYSE:TDOC) are related companies, but which is the better stock? We will contrast the two businesses based on the strength of their dividends, institutional ownership, valuation, media sentiment, earnings, analyst recommendations, profitability and risk.

Amazon.com has higher revenue and earnings than Teladoc Health. Teladoc Health is trading at a lower price-to-earnings ratio than Amazon.com, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Amazon.com$716.92B3.69$77.67B$8.3629.43
Teladoc Health$2.53B0.53-$200.32M-$0.97N/A

72.2% of Amazon.com shares are held by institutional investors. Comparatively, 76.8% of Teladoc Health shares are held by institutional investors. 8.9% of Amazon.com shares are held by insiders. Comparatively, 0.7% of Teladoc Health shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Amazon.com has a beta of 1.45, meaning that its stock price is 45% more volatile than the broader market. Comparatively, Teladoc Health has a beta of 2.14, meaning that its stock price is 114% more volatile than the broader market.

Amazon.com presently has a consensus price target of $312.78, indicating a potential upside of 27.11%. Teladoc Health has a consensus price target of $7.43, indicating a potential downside of 0.56%. Given Amazon.com's stronger consensus rating and higher possible upside, analysts clearly believe Amazon.com is more favorable than Teladoc Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Amazon.com
0 Sell rating(s)
3 Hold rating(s)
57 Buy rating(s)
0 Strong Buy rating(s)
2.95
Teladoc Health
1 Sell rating(s)
11 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.24

Amazon.com has a net margin of 12.22% compared to Teladoc Health's net margin of -6.81%. Amazon.com's return on equity of 19.92% beat Teladoc Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Amazon.com12.22% 19.92% 9.86%
Teladoc Health -6.81%-11.45%-5.54%

In the previous week, Amazon.com had 315 more articles in the media than Teladoc Health. MarketBeat recorded 321 mentions for Amazon.com and 6 mentions for Teladoc Health. Amazon.com's average media sentiment score of 0.97 beat Teladoc Health's score of 0.77 indicating that Amazon.com is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Amazon.com
202 Very Positive mention(s)
43 Positive mention(s)
45 Neutral mention(s)
22 Negative mention(s)
7 Very Negative mention(s)
Positive
Teladoc Health
3 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Amazon.com beats Teladoc Health on 14 of the 16 factors compared between the two stocks.

How does Teladoc Health compare to CRISPR Therapeutics?

Teladoc Health (NYSE:TDOC) and CRISPR Therapeutics (NASDAQ:CRSP) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their valuation, analyst recommendations, media sentiment, profitability, dividends, earnings, risk and institutional ownership.

Teladoc Health currently has a consensus price target of $7.43, suggesting a potential downside of 0.56%. CRISPR Therapeutics has a consensus price target of $67.78, suggesting a potential upside of 28.58%. Given CRISPR Therapeutics' stronger consensus rating and higher probable upside, analysts plainly believe CRISPR Therapeutics is more favorable than Teladoc Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Teladoc Health
1 Sell rating(s)
11 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.24
CRISPR Therapeutics
1 Sell rating(s)
7 Hold rating(s)
10 Buy rating(s)
1 Strong Buy rating(s)
2.58

76.8% of Teladoc Health shares are held by institutional investors. Comparatively, 69.2% of CRISPR Therapeutics shares are held by institutional investors. 0.7% of Teladoc Health shares are held by company insiders. Comparatively, 4.1% of CRISPR Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Teladoc Health has a beta of 2.14, indicating that its share price is 114% more volatile than the broader market. Comparatively, CRISPR Therapeutics has a beta of 1.74, indicating that its share price is 74% more volatile than the broader market.

Teladoc Health has higher revenue and earnings than CRISPR Therapeutics. CRISPR Therapeutics is trading at a lower price-to-earnings ratio than Teladoc Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Teladoc Health$2.53B0.53-$200.32M-$0.97N/A
CRISPR Therapeutics$3.51M1,448.48-$581.60M-$6.22N/A

Teladoc Health has a net margin of -6.81% compared to CRISPR Therapeutics' net margin of -13,856.54%. Teladoc Health's return on equity of -11.45% beat CRISPR Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
Teladoc Health-6.81% -11.45% -5.54%
CRISPR Therapeutics -13,856.54%-25.66%-20.39%

In the previous week, CRISPR Therapeutics had 6 more articles in the media than Teladoc Health. MarketBeat recorded 12 mentions for CRISPR Therapeutics and 6 mentions for Teladoc Health. CRISPR Therapeutics' average media sentiment score of 0.85 beat Teladoc Health's score of 0.77 indicating that CRISPR Therapeutics is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Teladoc Health
3 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
CRISPR Therapeutics
5 Very Positive mention(s)
1 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Teladoc Health beats CRISPR Therapeutics on 9 of the 17 factors compared between the two stocks.

How does Teladoc Health compare to Roku?

Roku (NASDAQ:ROKU) and Teladoc Health (NYSE:TDOC) are related companies, but which is the superior stock? We will compare the two businesses based on the strength of their risk, institutional ownership, media sentiment, earnings, dividends, analyst recommendations, valuation and profitability.

Roku has a net margin of 4.06% compared to Teladoc Health's net margin of -6.81%. Roku's return on equity of 7.64% beat Teladoc Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Roku4.06% 7.64% 4.61%
Teladoc Health -6.81%-11.45%-5.54%

Roku currently has a consensus price target of $148.42, suggesting a potential upside of 4.22%. Teladoc Health has a consensus price target of $7.43, suggesting a potential downside of 0.56%. Given Roku's stronger consensus rating and higher probable upside, equities analysts plainly believe Roku is more favorable than Teladoc Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Roku
0 Sell rating(s)
5 Hold rating(s)
21 Buy rating(s)
0 Strong Buy rating(s)
2.81
Teladoc Health
1 Sell rating(s)
11 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.24

Roku has a beta of 2.06, suggesting that its share price is 106% more volatile than the broader market. Comparatively, Teladoc Health has a beta of 2.14, suggesting that its share price is 114% more volatile than the broader market.

86.3% of Roku shares are held by institutional investors. Comparatively, 76.8% of Teladoc Health shares are held by institutional investors. 13.5% of Roku shares are held by insiders. Comparatively, 0.7% of Teladoc Health shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

In the previous week, Roku had 63 more articles in the media than Teladoc Health. MarketBeat recorded 69 mentions for Roku and 6 mentions for Teladoc Health. Teladoc Health's average media sentiment score of 0.77 beat Roku's score of 0.67 indicating that Teladoc Health is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Roku
27 Very Positive mention(s)
11 Positive mention(s)
22 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Positive
Teladoc Health
3 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

Roku has higher revenue and earnings than Teladoc Health. Teladoc Health is trading at a lower price-to-earnings ratio than Roku, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Roku$4.74B4.43$88.36M$1.33107.07
Teladoc Health$2.53B0.53-$200.32M-$0.97N/A

Summary

Roku beats Teladoc Health on 14 of the 16 factors compared between the two stocks.

How does Teladoc Health compare to Zoom Communications?

Teladoc Health (NYSE:TDOC) and Zoom Communications (NASDAQ:ZM) are related companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, profitability, media sentiment, dividends, risk, valuation, earnings and institutional ownership.

In the previous week, Zoom Communications had 9 more articles in the media than Teladoc Health. MarketBeat recorded 15 mentions for Zoom Communications and 6 mentions for Teladoc Health. Zoom Communications' average media sentiment score of 1.41 beat Teladoc Health's score of 0.77 indicating that Zoom Communications is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Teladoc Health
3 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
Zoom Communications
11 Very Positive mention(s)
2 Positive mention(s)
0 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

76.8% of Teladoc Health shares are held by institutional investors. Comparatively, 66.5% of Zoom Communications shares are held by institutional investors. 0.7% of Teladoc Health shares are held by insiders. Comparatively, 8.8% of Zoom Communications shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Zoom Communications has higher revenue and earnings than Teladoc Health. Teladoc Health is trading at a lower price-to-earnings ratio than Zoom Communications, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Teladoc Health$2.53B0.53-$200.32M-$0.97N/A
Zoom Communications$4.87B5.74$1.90B$6.8114.00

Teladoc Health has a beta of 2.14, indicating that its stock price is 114% more volatile than the broader market. Comparatively, Zoom Communications has a beta of 1.01, indicating that its stock price is 1% more volatile than the broader market.

Teladoc Health presently has a consensus target price of $7.43, suggesting a potential downside of 0.56%. Zoom Communications has a consensus target price of $109.33, suggesting a potential upside of 14.71%. Given Zoom Communications' stronger consensus rating and higher possible upside, analysts plainly believe Zoom Communications is more favorable than Teladoc Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Teladoc Health
1 Sell rating(s)
11 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.24
Zoom Communications
0 Sell rating(s)
12 Hold rating(s)
15 Buy rating(s)
0 Strong Buy rating(s)
2.56

Zoom Communications has a net margin of 41.99% compared to Teladoc Health's net margin of -6.81%. Zoom Communications' return on equity of 11.87% beat Teladoc Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Teladoc Health-6.81% -11.45% -5.54%
Zoom Communications 41.99%11.87%9.69%

Summary

Zoom Communications beats Teladoc Health on 14 of the 16 factors compared between the two stocks.

How does Teladoc Health compare to American Well?

American Well (NYSE:AMWL) and Teladoc Health (NYSE:TDOC) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, valuation, analyst recommendations, media sentiment, profitability, institutional ownership, earnings and risk.

In the previous week, Teladoc Health had 4 more articles in the media than American Well. MarketBeat recorded 6 mentions for Teladoc Health and 2 mentions for American Well. Teladoc Health's average media sentiment score of 0.77 beat American Well's score of 0.72 indicating that Teladoc Health is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
American Well
0 Very Positive mention(s)
2 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Teladoc Health
3 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

American Well has a beta of 1.69, meaning that its share price is 69% more volatile than the broader market. Comparatively, Teladoc Health has a beta of 2.14, meaning that its share price is 114% more volatile than the broader market.

American Well presently has a consensus target price of $7.20, indicating a potential downside of 20.13%. Teladoc Health has a consensus target price of $7.43, indicating a potential downside of 0.56%. Given Teladoc Health's stronger consensus rating and higher probable upside, analysts plainly believe Teladoc Health is more favorable than American Well.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
American Well
1 Sell rating(s)
3 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
Teladoc Health
1 Sell rating(s)
11 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.24

American Well has higher earnings, but lower revenue than Teladoc Health. Teladoc Health is trading at a lower price-to-earnings ratio than American Well, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
American Well$249.32M0.60-$95.70M-$5.42N/A
Teladoc Health$2.53B0.53-$200.32M-$0.97N/A

56.1% of American Well shares are owned by institutional investors. Comparatively, 76.8% of Teladoc Health shares are owned by institutional investors. 12.8% of American Well shares are owned by insiders. Comparatively, 0.7% of Teladoc Health shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Teladoc Health has a net margin of -6.81% compared to American Well's net margin of -37.02%. Teladoc Health's return on equity of -11.45% beat American Well's return on equity.

Company Net Margins Return on Equity Return on Assets
American Well-37.02% -32.11% -24.12%
Teladoc Health -6.81%-11.45%-5.54%

Summary

Teladoc Health beats American Well on 12 of the 16 factors compared between the two stocks.

Get Teladoc Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for TDOC and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TDOC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TDOC vs. The Competition

MetricTeladoc HealthMedical Services IndustryMedical SectorNYSE Exchange
Market Cap$1.35B$8.88B$6.49B$23.46B
Dividend YieldN/A1.71%2.67%4.05%
P/E Ratio-7.7024.2724.0531.85
Price / Sales0.5324.43542.61111.54
Price / Cash4.0813.7327.4818.65
Price / Book0.965.5510.694.75
Net Income-$200.32M$177.22M$3.57B$1.08B
7 Day Performance5.80%2.46%1.56%3.09%
1 Month Performance17.44%10.71%2.49%4.46%
1 Year Performance8.73%6.44%26.51%25.48%

Teladoc Health Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TDOC
Teladoc Health
1.2761 of 5 stars
$7.48
+1.8%
$7.43
-0.6%
+6.5%$1.35B$2.53BN/A5,600
AMZN
Amazon.com
4.9485 of 5 stars
$245.22
-0.3%
$312.52
+27.4%
+12.5%$2.64T$742.78B29.331,576,000
CRSP
CRISPR Therapeutics
3.5254 of 5 stars
$51.60
-0.5%
$65.47
+26.9%
+20.4%$4.98B$1MN/A460
ROKU
Roku
3.1242 of 5 stars
$123.57
+1.1%
$145.29
+17.6%
+93.1%$18.22B$4.97B92.913,600
ZM
Zoom Communications
4.6791 of 5 stars
$101.15
-0.5%
$109.33
+8.1%
+22.2%$29.66B$4.93B14.857,438

Related Companies and Tools


This page (NYSE:TDOC) was last updated on 6/15/2026 by MarketBeat.com Staff.
From Our Partners